A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Actavis Mid-Atlantic LLC
ClinicalTrials.gov Identifier:
NCT01502020
First received: December 23, 2011
Last updated: December 29, 2011
Last verified: December 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2011
  Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)